Form 8-K - Current report:
SEC Accession No. 0001564590-21-034630
Filing Date
2021-06-25
Accepted
2021-06-25 17:26:41
Documents
16
Period of Report
2021-06-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20210625.htm   iXBRL 8-K 37510
2 EX-99.1 fgen-ex991_76.htm EX-99.1 35025
3 GRAPHIC gjt1x2efzhln000002.jpg GRAPHIC 17196
4 GRAPHIC gjt1x2efzhln000003.jpg GRAPHIC 85979
5 GRAPHIC gjt1x2efzhln000001.jpg GRAPHIC 58417
  Complete submission text file 0001564590-21-034630.txt   431540

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fgen-20210625.xsd EX-101.SCH 5776
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20210625_lab.xml EX-101.LAB 18732
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20210625_pre.xml EX-101.PRE 11173
9 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20210625_htm.xml XML 3406
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 211049097
SIC: 2834 Pharmaceutical Preparations